
Heart failure (HF) and cirrhosis often lead to pleural effusions (PEs). Medical therapy involves diuretics, angiotensin receptor–neprilysin inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter 2 inhibitors for HF. Nonselective beta-blockers should be avoided in hepatic hydrothorax (HH). Refractory PEs are managed with repeated thoracentesis or indwelling pleural catheter (IPC) insertion. Diuretic-resistant HH may require transjugular intrahepatic portosystemic shunts as a bridge to liver transplantation. Diagnosis of pleural tuberculosis (TB) remains challenging, but nucleic acid amplification tests can improve accuracy. Treatment follows guidelines for pulmonary TB, with special considerations for HIV-coinfected patients and drug resistance.
Like
Save
Share